Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company iCura Vision
DescriptionOral inhibitor of retinol binding protein 4 plasma (RBP4)
Molecular Target Retinol binding protein 4 plasma (RBP4)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat dry age-related macular degeneration (AMD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today